FEF® BENZALKONIUM CHLORIDE is also known as BZK, BKC, BAK, alkyl dimethyl benzyl ammonium chloride and ADBAC. Our FeF Benzalkonium Chloride products have proven efficacy against a broad spectrum of microorganisms (gram + and – & acid fast bacteria, yeast, moulds, enveloped viruses). They are effective through a wide pH range, are surface active/adhesive cationic agents and do not add unpleasant odour/colour to finished formulations. Benzyl (dodecyl) dimethyl ammonium chloride (approx. 65%), Benzyl (tetradecyl) dimethyl ammonium chloride (approx. 35%). Approx. 50% active ingredients.

FEF® BENZALKONIUM CHLORIDE SOLUTION 50% is also known as BZK, BKC, BAK, alkyl dimethyl benzyl ammonium chloride and ADBAC. Our FeF Benzalkonium Chloride products have proven efficacy against a broad spectrum of microorganisms (gram + and – & acid fast bacteria, yeast, moulds, enveloped viruses). They are effective through a wide pH range, are surface active/adhesive cationic agents and do not add unpleasant odour/colour to finished formulations. Benzyl (dodecyl) dimethyl ammonium chloride (approx. 65%), Benzyl (tetradecyl) dimethyl ammonium chloride (approx. 35%). Approx. 50% active ingredients.

FEF® BENZALKONIUM CHLORIDE SOLUTION 50% (45/55) is also known as BZK, BKC, BAK, alkyl dimethyl benzyl ammonium chloride and ADBAC. Our FeF Benzalkonium Chloride products have proven efficacy against a broad spectrum of microorganisms (gram + and – & acid fast bacteria, yeast, moulds, enveloped viruses). They are effective through a wide pH range, are surface active/adhesive cationic agents and do not add unpleasant odour/colour to finished formulations. Benzyl (dodecyl) dimethyl ammonium chloride (approx. 45%), Benzyl (tetradecyl) dimethyl ammonium chloride (approx. 55%). Approx. 50% active ingredients.

Atorvastatin Calcium, provided by Refarmed Chemicals, is a potent pharmaceutical ingredient used by healthcare professionals in the management and prevention of several cardiovascular-related conditions. As an integral part of the statin class of medications, Atorvastatin Calcium serves a critical role in reducing cholesterol levels, specifically low-density lipoprotein (LDL) cholesterol, apolipoprotein B, and total cholesterol. It is also effective in lowering triglyceride levels and is indicated for the prevention of cardiovascular events such as ischemic strokes and transient ischemic attacks, particularly in patients who are at high risk of these events. This product is especially valuable for the treatment of familial heterozygous and homozygous hypercholesterolemia. However, it is contraindicated in individuals with known hypersensitivity to the active ingredient, those suffering from active liver disease, and should not be used during pregnancy and breastfeeding due to potential risks. Formulated as a white or almost white yellowish crystalline powder, Atorvastatin Calcium comes with comprehensive documentation and certifications, such as the Certificate of Suitability (CEP) and Good Manufacturing Practice (GMP) standards, ensuring its quality and safety. The material's purity is rigorously controlled, with an assay requirement of 98.0% to 102.0%, minimal water content, and strict limits on enantiomer impurities as well as residual solvents such as Methanol and Methyl tert-butyl ether, as specified in the provided image of its typical properties. Patients prescribed Atorvastatin Calcium should be under close medical supervision to monitor liver function and signs of muscle damage, a potential adverse effect. Muscle pain, diarrhea, nausea, headache, and flatulence are among the commonly reported side effects. Moreover, Atorvastatin Calcium can interact with several other medications, necessitating careful review by healthcare professionals when determining a patient's regimen. Refarmed Chemicals' rigorous adherence to quality and patient safety, as exemplified by their Atorvastatin Calcium product, fulfills the expectation of effectiveness and reliability desired by healthcare providers and wholesalers looking to distribute a product that can make a significant impact on public health.

Products still subject to third-party patent protection might be available solely for R&D purposes.